(Q39308078)

10 September 2017

title

Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation (English)

1 reference

10 September 2017

0 references

chronic myeloid leukemia

0 references

1 reference

Jun Lee

1

1 reference

10 September 2017

Guobing Zhang

2

1 reference

10 September 2017

Xiuhua Wu

3

1 reference

10 September 2017

Feilong Xu

4

1 reference

10 September 2017

Jun Zhou

5

1 reference

10 September 2017

Xingguo Zhang

6

1 reference

10 September 2017

publication date

26 July 2012

1 reference

Journal of Cancer Research and Clinical Oncology

10 September 2017

published in

1 reference

10 September 2017

volume

138

1 reference

10 September 2017

issue

12

1 reference

10 September 2017

page(s)

2095-2102

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-012-1292-1

10 September 2017

exact match

0 references

cites work

Molecular pathways: BCR-ABL.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1α in human rheumatoid arthritis fibroblast-like synoviocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Overview of cell death signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Single-cell analysis of dihydroartemisinin-induced apoptosis through reactive oxygen species-mediated caspase-8 activation and mitochondrial pathway in ASTC-a-1 cells using fluorescence imaging techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1292-1

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells

21 January 2018

1 reference

12 December 2020

Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo

1 reference

12 December 2020

Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3

1 reference

12 December 2020

Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers.

1 reference

12 December 2020

BCR-ABL delays apoptosis upstream of procaspase-3 activation

1 reference

12 December 2020

The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu

1 reference

12 December 2020

Signaling networks associated with BCR-ABL-dependent transformation

1 reference

12 December 2020

Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia

1 reference

12 December 2020

10.1007/S00432-012-1292-1

Identifiers

DOI

1 reference

10 September 2017

1 reference